Home » Newsletters » BioWorld Science

BioWorld Science

June 2, 1997

View Archived Issues

Positive preclinical results for Inflazyme's Apanol

Protein Sciences' influenza vaccine covered under U.S. patent

Vion antiinfective covered under U.S. patent

T Cell Sciences completes patient enrollment for reperfusion injury trial

FDA advisory committee review of EchoGen postponed

Lilly and Megabios enter gene-based therapeutics collaboration

Xenova and Warner-Lambert enter further drug discovery collaboration

Wyeth-Ayerst's Normiflo approved for prevention of deep vein thrombosis

AMBI reports positive results for Cardia Salt Alternative

HIV drug resistance test launched by Murex

MS&D prepares CCK-B/gastrin receptor antagonists

Cephems active against MRSA reported by Bristol-Myers Squibb

Ion channel-forming peptides from Magainin

Mallinckrodt describes new imaging agents

Merck & Co. discloses pneumococcal vaccines

Antimigraine agents from Janssen

Lilly describes agents for Alzheimer's disease

Antiallergic/antiasthmatic agents from Sumitomo Metal

Company Profile: AntiVirals

Astra shifts focus to newer thrombin inhibitor

BTI-322 preclinical and clinical data disclosed at transplant meeting

Anti-LFA-1 MAbs for transplantation

Leflunomide preclinical results presented at transplant congress

Agouron reports structure-based design of calcineurin inhibitors

New NSAID under development in Russia

Molecular structure of prostaglandins responsible for HSF1 activation elucidated

Cardioprotective effects of K-7259 in rat hearts

New i.v. formulation of amiodarone better tolerated in patients

Clinical electrophysiological and hemodynamic effects of BRL-32872A

Mechanism of antiarrhythmic effect of UK-14304

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...